Caricamento in corso... Attendere.
Profilo società
Sequana Medical N.V. is a commercial stage medical device company utilizing its proprietary alfapump® and DSR® (Direct Sodium Removal) technologies to develop innovative treatments for fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump is a fully-implanted, wireless device that automatically pumps fluid from the abdomen into the bladder, where it is removed naturally through urination. The alfapump is CE-marked for the management of refractory ascites due to liver cirrhosis and malignant ascites and has been granted breakthrough device designation by the US FDA with a North American pivotal study underway. DSR is a novel approach to manage sodium and fluid overload through use of a sodium-free infusate administered into the abdominal cavity. The alfapump DSR® combines DSR therapy with the proven alfapump platform and is in clinical development as potential treatment for decompensated heart failure patients.
Fonte:
Cofisem
-
Ultimo aggiornamento:
16 Oct 2024
Dirigenti principali
| Chief Executive Officer | Ian Crosbie | ||||
| Chief Financial Officer | Kirsten Van Bockstaele | ||||
| Chief Commercial Officer | Martijn Blom | ||||
| Fonte: Cofisem - Ultimo aggiornamento: 16 Oct 2024 | |||||
Dati principali
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 712 | 923 | 371 | 963 | 971 |
| Income from ordinary activities | 712 | 923 | 371 | 963 | 971 |
| Operating income | -28.862 | -28.094 | -22.614 | -17.771 | -13.964 |
| Cost of financial indebtedness net | 1.989 | 880 | 466 | 1.066 | 771 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | -32.564 | -30.763 | -23.615 | -19.106 | -14.977 |
| Net income (Group share) | -32.564 | -30.763 | -23.615 | -19.106 | -14.977 |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
| Fonte: Cofisem - Ultimo aggiornamento: 16 Oct 2024 | |||||
Informazioni sull’azionariato
Indirizzo
Sequana Medical N.V.
Kortrijksesteenweg 1112
box 102
BE-9051
Sint-Denijs-Westrem
Belgium
Telefono:
+32 9 298 2828
Fonte:
Cofisem
-
Ultimo aggiornamento:
16 Oct 2024
Contatto
Lies Vanneste
Telefono: +32 498 053579
Fonte: Sequana Medical N.V. - Ultimo aggiornamento: 16 Oct 2024